The differential activity of interferon-α subtypes is consistent among distinct target genes and cell types

Cytokine

Volumn 53, Issue 1, 2011, Pages 52-59

  Moll, Herwig P ^a   Maier, Thomas ^a   Zommer, Anna ^a   Lavoie, Thomas ^b   Brostjan, Christine ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b PBL InterferonSource   (United States)

Author keywords

Endothelial cells; Fibroblasts; IFN ; Interferon stimulated genes; Subtypes

Indexed keywords

ALPHA INTERFERON; ALPHA1 INTERFERON; ALPHA10 INTERFERON; ALPHA14 INTERFERON; ALPHA16 INTERFERON; ALPHA21 INTERFERON; ALPHA2A INTERFERON; ALPHA2B INTERFERON; ALPHA4A INTERFERON; ALPHA4B INTERFERON; ALPHA5 INTERFERON; ALPHA6 INTERFERON; ALPHA7 INTERFERON; ALPHA8 INTERFERON; CXCL11 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 2; PROTEIN IFIT1; PROTEIN ISG15; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BIOLOGICAL ACTIVITY; CELL ACTIVATION; CELL ACTIVITY; CELL ISOLATION; CELL PROTECTION; CELL SPECIFICITY; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBROBLAST CULTURE; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE TARGETING; HUMAN; HUMAN CELL; INFLUENZA; LYMPH VESSEL ENDOTHELIUM; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; TRANSCRIPTION REGULATION;

ANTIVIRAL AGENTS; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-ALPHA; KINETICS; MALE; ORGAN SPECIFICITY; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION FACTORS;

ORTHOMYXOVIRIDAE;

EID: 78349307010     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.09.006     Document Type: Article

References (32)

1. Isaacs A., Lindenmann J. Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 1957, 147:258-267.
2. Pestka S., Krause C.D., Walter M.R. Interferons, interferon-like cytokines, and their receptors. Immunol Rev 2004, 202:8-32.
3. Diaz M.O., Pomykala H.M., Bohlander S.K., Maltepe E., Malik K., Brownstein B., et al. Structure of the human type-I interferon gene cluster determined from a YAC clone contig. Genomics 1994, 22:540-552.
4. Chen J., Baig E., Fish E.N. Diversity and relatedness among the type I interferons. J Interferon Cytokine Res 2004, 24:687-698.
5. Platanias L.C. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 2005, 5:375-386.
6. Stark G.R. How cells respond to interferons revisited: from early history to current complexity. Cytokine Growth Factor Rev 2007, 18:419-423.
7. Foster G.R., Rodrigues O., Ghouze F., Schulte-Frohlinde E., Testa D., Liao M.J., et al. Different relative activities of human cell-derived interferon-alpha subtypes: IFN-alpha 8 has very high antiviral potency. J Interferon Cytokine Res 1996, 16:1027-1033.
8. Yamamoto S., Yano H., Sanou O., Ikegami H., Kurimoto M., Kojiro M. Different antiviral activities of IFN-alpha subtypes in human liver cell lines: synergism between IFN-alpha2 and IFN-alpha8. Hepatol Res 2002, 24:99.
9. Cull V.S., Tilbrook P.A., Bartlett E.J., Brekalo N.L., James C.M. Type I interferon differential therapy for erythroleukemia: specificity of STAT activation. Blood 2003, 101:2727-2735.
10. Genin P., Vaccaro A., Civas A. The role of differential expression of human interferon - a genes in antiviral immunity. Cytokine Growth Factor Rev 2009, 20:283-295.
11. Jaitin D.A., Roisman L.C., Jaks E., Gavutis M., Piehler J., Van der Heyden J., et al. Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta. Mol Cell Biol 2006, 26:1888-1897.
12. Tanimoto T., Yamamoto S., Taniai M., Taniguchi M., Ariyasu H., Ushio C., et al. The combination of IFN-alpha2 and IFN-alpha8 exhibits synergistic antiproliferative activity on renal cell carcinoma (RCC) cell lines through increased binding affinity for IFNAR-2. J Interferon Cytokine Res 2007, 27:517-523.
13. da Silva A.J., Brickelmaier M., Majeau G.R., Lukashin A.V., Peyman J., Whitty A., et al. Comparison of gene expression patterns induced by treatment of human umbilical vein endothelial cells with IFN-alpha 2b versus IFN-beta 1a: understanding the functional relationship between distinct type I interferons that act through a common receptor. J Interferon Cytokine Res 2002, 22:173-188.
14. Koyama T., Sakamoto N., Tanabe Y., Nakagawa M., Itsui Y., Takeda Y., et al. Divergent activities of interferon-alpha subtypes against intracellular hepatitis C virus replication. Hepatol Res 2006, 34:41-49.
15. Foster G.R., Masri S.H., David R., Jones M., Datta A., Lombardi G., et al. IFN-alpha subtypes differentially affect human T cell motility. J Immunol 2004, 173:1663-1670.
16. Hannigan G.E., Gewert D.R., Fish E.N., Read S.E., Williams B.R. Differential binding of human interferon-alpha subtypes to receptors on lymphoblastoid cells. Biochem Biophys Res Commun 1983, 110:537-544.
17. Geiss G.K., Carter V.S., He Y., Kwieciszewski B.K., Holzman T., Korth M.J., et al. Gene expression profiling of the cellular transcriptional network regulated by alpha/beta interferon and its partial attenuation by the hepatitis C virus nonstructural 5A protein. J Virol 2003, 77:6367-6375.
18. Yano H., Yanai Y., Momosaki S., Ogasawara S., Akiba J., Kojiro S., et al. Growth inhibitory effects of interferon-alpha subtypes vary according to human liver cancer cell lines. J Gastroenterol Hepatol 2006, 21:1720-1725.
19. Indraccolo S., Pfeffer U., Minuzzo S., Esposito G., Roni V., Mandruzzato S., et al. Identification of genes selectively regulated by IFNs in endothelial cells. J Immunol 2007, 178:1122-1135.
20. Bergmann M., Romirer I., Sachet M., Fleischhacker R., Garcia-Sastre A., Palese P., et al. A genetically engineered influenza A virus with ras-dependent oncolytic properties. Cancer Res 2001, 61:8188-8193.
21. Hardy M.P., Owczarek C.M., Jermiin L.S., Ejdeback M., Hertzog P.J. Characterization of the type I interferon locus and identification of novel genes. Genomics 2004, 84:331-345.
22. Nyman T.A., Tolo H., Parkkinen J., Kalkkinen N. Identification of nine interferon-alpha subtypes produced by Sendai virus-induced human peripheral blood leucocytes. Biochem J 1998, 329(Pt 2):295-302.
23. Szubin R., Chang W.L., Greasby T., Beckett L., Baumgarth N. Rigid interferon-alpha subtype responses of human plasmacytoid dendritic cells. J Interferon Cytokine Res 2008.
24. Brandt E.R., Linnane A.W., Devenish R.J. Expression of IFN A genes in subpopulations of peripheral blood cells. Br J Haematol 1994, 86:717-725.
25. Loseke S., Grage-Griebenow E., Wagner A., Gehlhar K., Bufe A. Differential expression of IFN-alpha subtypes in human PBMC: evaluation of novel real-time PCR assays. J Immunol Methods 2003, 276:207-222.
26. Yanai Y., Sanou O., Yamamoto K., Yamauchi H., Ikegami H., Kurimoto M. The anti-tumor activities of interferon (IFN)-alpha in chronic myelogenous leukaemia (CML)-derived cell lines depends on the IFN-alpha subtypes. Cancer Lett 2002, 185:173-179.
27. Kumaran J., Wei L., Kotra L.P., Fish E.N. A structural basis for interferon-alpha-receptor interactions. FASEB J 2007, 21:3288-3296.
28. Guo J., Peters K.L., Sen G.C. Induction of the human protein P56 by interferon, double-stranded RNA, or virus infection. Virology 2000, 267:209-219.
29. Terenzi F., Hui D.J., Merrick W.C., Sen G.C. Distinct induction patterns and functions of two closely related interferon-inducible human genes, ISG54 and ISG56. J Biol Chem 2006, 281:34064-34071.
30. D'Cunha J., Knight E., Haas A.L., Truitt R.L., Borden E.C. Immunoregulatory properties of ISG15, an interferon-induced cytokine. Proc Natl Acad Sci USA 1996, 93:211-215.
31. Sadler A.J., Williams B.R. Interferon-inducible antiviral effectors. Nat Rev Immunol 2008, 8:559-568.
32. Hilkens C.M., Schlaak J.F., Kerr I.M. Differential responses to IFN-alpha subtypes in human T cells and dendritic cells. J Immunol 2003, 171:5255-5263.